The dysregulation of PA metabolism is commonly associated with various diseases [33–35], suggesting that such PAOX upregulation-caused PA dysregulation may give helpful insight into a therapeutic benefit of IDD. This evidence concerns the gene PAOX and intervertebral disk degenerative disorder.